Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) [Phase 2]
A Phase 2 prospective, multi-centre trial evaluating redifferentiation therapy in patients with radioiodine-refractory thyroid cancer (I-FIR…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer [Phase 3]
A Phase III clinical trial evaluating prophylactic central neck dissection in low-risk papillary thyroid cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2023-09-25Clinical Trial Update: Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea) [Phase 1, Phase 2]
Early-phase clinical trial updates a patient-customized bioprinting approach aimed at regenerating the respiratory tract (trachea) with an o…
-
FDA label_change · 2023-08-09FDA Approved: GAVRETO — Supplemental Application (Genentech, Inc.)
Genentech filed a supplemental application for Gavreto (pralsetinib) with the FDA. The action seeks a label update that could expand indicat…
-
FDA approval · 2023-07-21FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Levothyroxine Sodium, a generic product used to treat hypothyroidism and re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-14Clinical Trial Update: Molecular Testing to Direct Extent of Initial Thyroid Surgery [Phase 2]
Phase 2 clinical trial evaluating molecular testing to guide the extent of initial thyroid surgery for thyroid cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition [Phase 2]
Phase 2 clinical trial investigating MAPK inhibition to enhance radioiodine uptake in radioiodine-refractory metastatic thyroid cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors [Phase 1, Phase 2]
A Phase I/II study investigating regorafenib in combination with avelumab in various solid tumors, spanning Phase 1 and Phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of Enapotamab Vedotin in solid tumors, including ovarian and cervical cancer; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating intensity-modulated radiation therapy (IMRT) for non-anaplastic non-medullary thyroid cancer has completed…
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer [Phase 2]
A Phase 2 clinical trial evaluating PD-1 inhibitor plus anlotinib with multimodal radiotherapy for recurrent or metastatic anaplastic thyroi…
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer [Phase 3]
A Phase 3 trial evaluating whether metformin affects fertility in women treated with radioactive iodine (131I) for thyroid cancer is not yet…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer [Phase 2]
Phase 2 trial investigating total thyroidectomy with or without prophylactic central neck lymph node dissection in low-risk papillary thyroi…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients [Phase 4]
Phase 4 clinical trial update on 99mTc Sestamibi scans in thyroglobulin-positive, scan-negative differentiated thyroid cancer patients; stat…
-
FDA label_change · 2022-04-14FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
FDA approved a supplemental application for Levothyroxine Sodium submitted by Alvogen, Inc., resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma [Phase 4]
Phase 4 clinical study evaluating the effect of selenium yeast capsules on prognosis in differentiated thyroid carcinoma, with an unclear st…
-
CLINICAL_TRIALS research · 2022-02-18Clinical Trial Update: Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients. [Phase 4]
A Phase 4 trial exploring how a Type 2 Deiodinase gene polymorphism affects treatment of hypothyroidism in thyroid cancer patients post-thyr…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Anlotinib or Penpulimab in Combination With RAI for DTC [Phase 2]
Phase 2 clinical trial exploring anlotinib or penpulimab in combination with radioactive iodine for differentiated thyroid cancer.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Study of Apatinib in Patients With Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update of apatinib in differentiated thyroid cancer has completed.
-
FDA approval · 2021-11-10FDA Approved: GAVRETO — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Gavreto (pralsetinib) filed by Genentech, expanding its label for RET fusion–positive cancer…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: RAD001 for Patients With Radioiodine Refractory Thyroid Cancer [Phase 2]
Phase 2 clinical trial update for RAD001 in patients with radioiodine refractory thyroid cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating whether adding selumetinib to radioactive iodine improves outcomes in patients with recurrent or metastatic thyroid…
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating Gallium-68 PSMA PET for diagnosing thyroid cancer; study terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating irofulven in combination with capecitabine for advanced thyroid cancer has been completed.